Cover Image
市場調查報告書

數位PCR (dPCR) 及定量PCR (qPCR) 的全球市場預測 ∼2021年:各技術、產品、用途、終端用戶

Digital PCR (dPCR) and qPCR Market by Technology (Quantitative, Digital), Product (Instrument, Reagent, Software), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, Pharma-Biotech Co) - Global Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 324624
出版日期 內容資訊 英文 191 Pages
訂單完成後即時交付
價格
Back to Top
數位PCR (dPCR) 及定量PCR (qPCR) 的全球市場預測 ∼2021年:各技術、產品、用途、終端用戶 Digital PCR (dPCR) and qPCR Market by Technology (Quantitative, Digital), Product (Instrument, Reagent, Software), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, Pharma-Biotech Co) - Global Forecasts to 2021
出版日期: 2016年04月06日 內容資訊: 英文 191 Pages
簡介

全球數位PCR (dPCR) 及定量PCR (qPCR) 市場,預計從2016年的32億8000萬美元以8.5%的年複合成長率 (CAGR) 擴大,2021年達到49億4000萬美元。該成長的要素為,感染疾病和遺傳性疾病的發病率上升,技術的進步,官民的投資、資金、津貼的增加,醫院及診斷中心的增加等提高。

本報告提供全球數位PCR (dPCR) 及定量PCR (qPCR) 市場相關調查分析,各產業、產品、終端用戶、用途,及各地區的市場分析與預測,競爭情形分析,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 定量PCR (qPCR) 及數位PCR (dPCR) 的全球市場
  • 全球qPCR、dPCR技術市場:各地區
  • 全球qPCR、dPCR的市場佔有率:各產品及服務
  • 全球qPCR、dPCR市場:各應用領域
  • 全球qPCR、dPCR的市場佔有率:各應用領域
  • 全球qPCR、dPCR的市場佔有率:各終端用戶

第5章 市場概要

  • 簡介
  • 數位PCR (dPCR) 、定量PCR (qPCR) 的技術創新
  • 市場分類
  • 市場動態
    • 市場發展因素
    • 市場發展阻礙要素
    • 課題

第6章 產業趨勢

  • 簡介
  • 價值鏈分析
  • 產業趨勢
  • 波特的五力分析

第7章 全球qPCR、dPCR市場:各技術

  • 簡介
  • 定量PCR (qPCR)
  • 數位PCR (dPCR)

第8章 全球qPCR、dPCR市場:各產品及服務

  • 簡介
  • qPCR產品及服務
    • 試劑、消耗品
    • 器具
    • 軟體及服務
  • dPCR產品及服務
    • 器具
    • 試劑、消耗品
    • 軟體及服務

第9章 qPCR、dPCR市場:各用途

  • 簡介
  • qPCR
    • 臨床
    • 研究
    • 司法鑑定
  • dPCR
    • 臨床
    • 研究
    • 司法鑑定

第10章 qPCR、dPCR市場:各終端用戶

  • 簡介
  • qPCR
    • 醫院、診斷中心
    • 研究所、學術機構
    • 醫藥品、生物科技企業
    • 臨床研究機關
    • 司法鑑定機關
  • dPCR
    • 研究所、學術機構
    • 醫院、診斷中心
    • 醫藥品、生物科技企業
    • 臨床研究機關
    • 司法鑑定機關

第11章 qPCR、dPCR市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第12章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形
  • 近幾年的發展趨勢

第13章 企業簡介

  • 簡介
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • TaKaRa BIO
  • Biomerieux S.A
  • Affymetrix, Inc.
  • Fluidigm Corporation
  • Raindance Technologies, Inc.

第14章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 3161

The global qPCR and dPCR market is expected to reach USD 4.94 billion by 2021 from USD 3.28 billion in 2016, growing at a CAGR of 8.5% during the forecast period. Market growth can be attributed to the rising incidences of infectious diseases and genetic disorders (coupled with growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancements; increasing public-private investments, funds, and grants; successful completion of the Human Genome Project, and rise in the number of hospitals and diagnostic centers.

In this report, the global qPCR and dPCR market is segmented on the basis of technology, products and services, applications, and end users. On the basis of technology, the market is further segmented into qPCR and dPCR. On the basis of products and services, the market is further segmented into instruments, reagents, and consumables; software; and services. On the basis of applications, the market is further segmented into clinical applications, research applications, and forensic applications. On the basis of end users, the market is further segmented into research labs and academic institutes, pharma and biotech companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories.

Geographically, North America is expected to account for the largest share of the global qPCR and dPCR market in 2016, followed by Europe. Factors such as increase in public and private funding and increasing financial support (in the form of research grants and funding projects) from prominent funding agencies and federal institutions for the R&D of innovative qPCR and dPCR products are driving the qPCR and dPCR market in the North America region. However, Asia-Pacific (comprising China, India, Japan, and the Rest of Asia-Pacific) is projected to be the fastest-growing region in the qPCR and dPCR market during the forecast period, owing to factors such as increasing focus of global life sciences companies on this region, burgeoning efforts to increase awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel qPCR and dPCR technologies, growth in the Indian genomics market, and strengthening cancer research in Japan, among others.

In 2015, the global qPCR and dPCR devices market was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (The Netherlands), and Agilent Technologies, Inc. (U.S.). These top five market players jointly accounted for ~87.0% of the global qPCR and dPCR market in 2015.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the qPCR and dPCR market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the qPCR and dPCR products offered by the top 10 players in the global market. The report analyzes the qPCR and dPCR products market by products and services, applications, and end users across key geographic regions
  • Product Development/Innovation: Detailed insights on upcoming qPCR and dPCR products, research and development activities, and new product launches in the market
  • Market Development: Comprehensive information on the lucrative emerging markets. The report analyzes the markets for various qPCR and dPCR products across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global qPCR and dPCR market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global qPCR and dPCR market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. STUDY OBJECTIVES
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. FACTOR ANALYSIS
    • 2.2.1. INTRODUCTION
    • 2.2.2. DEMAND-SIDE ANALYSIS
      • 2.2.2.1. Healthcare expenditure patterns
      • 2.2.2.2. Rapid growth of aging population
      • 2.2.2.3. Incidence and prevalence of cancer
      • 2.2.2.4. Birth rate/pregnancies
      • 2.2.2.5. Burden of infectious diseases
      • 2.2.2.6. Number of clinical, forensics, and research laboratories
    • 2.2.3. SUPPLY-SIDE ANALYSIS
      • 2.2.3.1. Number of new product launches: qPCR and dPCR Vs. competitive technologies
      • 2.2.3.2. Parent market analysis: Polymerase chain reaction (PCR) market
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. TOP-DOWN APPROACH
    • 2.3.2. BOTTOM-UP APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS
    • 2.5.1. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. HISTORY, EVOLUTION, AND CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL qPCR AND dPCR MARKET (2016-2021)
  • 4.2. GLOBAL qPCR AND dPCR TECHNOLOGY MARKET, BY REGION (2016-2021)
  • 4.3. GLOBAL qPCR AND dPCR MARKET SHARE, BY PRODUCT AND SERVICE (2016)
  • 4.4. GLOBAL qPCR AND dPCR MARKET, BY APPLICATION (2016)
  • 4.5. GLOBAL qPCR AND dPCR MARKET SHARE, BY APPLICATION (2016)
  • 4.6. GLOBAL qPCR AND dPCR MARKET SHARE, BY END USER (2016-2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. TECHNOLOGICAL EVOLUTION IN qPCR/dPCR
  • 5.3. MARKET SEGMENTATION
  • 5.4. MARKET DYNAMICS
    • 5.4.1. DRIVERS
      • 5.4.1.1. Rising incidences of infectious diseases and genetic disorders
      • 5.4.1.2. Technological advancements
      • 5.4.1.3. Increasing public-private investments, funds, and grants
      • 5.4.1.4. Successful completion of the Human Genome Project
    • 5.4.2. RESTRAINTS
      • 5.4.2.1. High device costs associated with dPCR
      • 5.4.2.2. Technical limitations of qPCR and dPCR techniques
    • 5.4.3. OPPORTUNITIES
      • 5.4.3.1. Growing market penetration in emerging countries
      • 5.4.3.2. Shift from plant-derived to genome-based drug discovery
    • 5.4.4. CHALLENGES
      • 5.4.4.1. Adoption and implementation of MIQE guidelines for publishing qPCR and dPCR-based research

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. INDUSTRY TRENDS
    • 6.3.1. DEVELOPMENT OF LAB-ON-CHIP PCR DEVICES
    • 6.3.2. ONGOING TECHNOLOGICAL INTEGRATION WITH PCR PROCESS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. REAL-TIME PCR (qPCR) MARKET: PORTER'S FIVE FORCES ANALYSIS
      • 6.4.1.1. Threat from new entrants
      • 6.4.1.2. Threat from substitutes
      • 6.4.1.3. Bargaining power of suppliers
      • 6.4.1.4. Bargaining power of buyers
      • 6.4.1.5. Intensity of competitive rivalry
    • 6.4.2. DIGITAL PCR (dPCR) MARKET: PORTER'S FIVE FORCES ANALYSIS
      • 6.4.2.1. Threat from new entrants
      • 6.4.2.2. Threat from substitutes
      • 6.4.2.3. Bargaining power of suppliers
      • 6.4.2.4. Bargaining power of buyers
      • 6.4.2.5. Intensity of competitive rivalry

7. GLOBAL qPCR AND dPCR MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. QUANTITATIVE PCR (qPCR)
  • 7.3. DIGITAL PCR (dPCR)

8. GLOBAL qPCR AND dPCR MARKET, BY PRODUCT AND SERVICES

  • 8.1. INTRODUCTION
  • 8.2. qPCR PRODUCT AND SERVICES
    • 8.2.1. qPCR REAGENTS AND CONSUMABLES
    • 8.2.2. qPCR INSTRUMENTS
    • 8.2.3. qPCR SOFTWARE AND SERVICES
  • 8.3. dPCR PRODUCT AND SERVICES
    • 8.3.1. dPCR INSTRUMENTS
    • 8.3.2. dPCR REAGENTS AND CONSUMABLES
    • 8.3.3. dPCR SOFTWARE AND SERVICES

9. qPCR AND dPCR MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. qPCR APPLICATIONS
    • 9.2.1. CLINICAL APPLICATIONS
    • 9.2.2. RESEARCH APPLICATIONS
    • 9.2.3. FORENSIC APPLICATIONS
  • 9.3. dPCR APPLICATIONS
    • 9.3.1. CLINICAL APPLICATIONS
    • 9.3.2. RESEARCH APPLICATIONS
    • 9.3.3. FORENSIC APPLICATIONS

10. qPCR AND dPCR MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. QUANTITATIVE PCR (qPCR) END USERS
    • 10.2.1. HOSPITALS AND DIAGNOSTIC CENTERS
    • 10.2.2. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
    • 10.2.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 10.2.4. CLINICAL RESEARCH ORGANIZATIONS
    • 10.2.5. FORENSIC LABORATORIES
  • 10.3. DIGITAL PCR (dPCR) END USERS
    • 10.3.1. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
    • 10.3.2. HOSPITALS AND DIAGNOSTIC CENTERS
    • 10.3.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 10.3.4. CLINICAL RESEARCH ORGANIZATIONS
    • 10.3.5. FORENSIC LABORATORIES

11. qPCR AND dPCR MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
  • 11.3. EUROPE
  • 11.4. ASIA-PACIFIC
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
    • 12.2.1. qPCR MARKET SHARE ANALYSIS (2015)
    • 12.2.2. dPCR MARKET SHARE ANALYSIS (2015)
  • 12.3. COMPETITIVE SCENARIO
  • 12.4. RECENT DEVELOPMENTS
    • 12.4.1. NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
    • 12.4.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 12.4.3. MERGERS AND ACQUISITIONS
    • 12.4.4. GEOGRAPHICAL EXPANSIONS
    • 12.4.5. OTHER DEVELOPMENTS

13. COMPANY PROFILES

  • 13.1. INTRODUCTION
    • 13.1.1. GEOGRAPHIC BENCHMARKING
    • 13.1.2. STRATEGIC OUTLOOK
      • 13.1.2.1. Product development and commercialization
  • 13.2. THERMO FISHER SCIENTIFIC, INC.
    • 13.2.1. BUSINESS OVERVIEW
    • 13.2.2. PRODUCTS & SERVICES
    • 13.2.3. RECENT DEVELOPMENTS
    • 13.2.4. MNM VIEW
  • 13.3. BIO-RAD LABORATORIES, INC.
    • 13.3.1. BUSINESS OVERVIEW
    • 13.3.2. PRODUCTS & SERVICES
    • 13.3.3. RECENT DEVELOPMENTS
    • 13.3.4. MNM VIEW
  • 13.4. F. HOFFMAN-LA ROCHE LTD.
    • 13.4.1. BUSINESS OVERVIEW
    • 13.4.2. PRODUCTS & SERVICES
    • 13.4.3. RECENT DEVELOPMENTS
    • 13.4.4. MNM VIEW
  • 13.5. QIAGEN N.V.
    • 13.5.1. BUSINESS OVERVIEW
    • 13.5.2. PRODUCTS OFFERED
    • 13.5.3. RECENT DEVELOPMENTS
    • 13.5.4. MNM VIEW
  • 13.6. AGILENT TECHNOLOGIES, INC.
    • 13.6.1. BUSINESS OVERVIEW
    • 13.6.2. PRODUCTS OFFERED
    • 13.6.3. RECENT DEVELOPMENTS
    • 13.6.4. MNM VIEW
  • 13.7. TAKARA BIO, INC.
    • 13.7.1. BUSINESS OVERVIEW
    • 13.7.2. PRODUCTS OFFERED
    • 13.7.3. RECENT DEVELOPMENTS
  • 13.8. BIOMERIEUX S.A.
    • 13.8.1. BUSINESS OVERVIEW
    • 13.8.2. PRODUCTS & SERVICES
    • 13.8.3. RECENT DEVELOPMENTS
  • 13.9. AFFYMETRIX, INC.
    • 13.9.1. BUSINESS OVERVIEW
    • 13.9.2. PRODUCTS OFFERED
    • 13.9.3. RECENT DEVELOPMENTS
  • 13.10. FLUIDIGM CORPORATION
    • 13.10.1. BUSINESS OVERVIEW
    • 13.10.2. PRODUCTS OFFERED
    • 13.10.3. RECENT DEVELOPMENTS
  • 13.11. RAINDANCE TECHNOLOGIES, INC.
    • 13.11.1. BUSINESS OVERVIEW
    • 13.11.2. PRODUCTS AND SERVICES
    • 13.11.3. RECENT DEVELOPMENTS

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GLOBAL qPCR AND dPCR MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 2: GLOBAL qPCR TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 3: GLOBAL dPCR TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: GLOBAL qPCR PRODUCTS AND SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: qPCR REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: qPCR INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: qPCR SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: GLOBAL dPCR PRODUCT AND SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 9: dPCR INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: dPCR REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: dPCR SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 13: qPCR CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: qPCR RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: qPCR FORENSIC APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 17: dPCR CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: dPCR RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: DPCR FORENSIC APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 21: qPCR MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: qPCR MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: qPCR MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: qPCR MARKET SIZE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: qPCR MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 27: dPCR MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: dPCR MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: dPCR MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: dPCR MARKET SIZE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: dPCR MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: qPCR AND dPCR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 40: U.S.: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 41: U.S.: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 42: U.S.: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 43: U.S.: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 44: U.S.: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: DPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 51: ASIA-PACIFIC: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 52: ASIA-PACIFIC: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 53: ASIA-PACIFIC: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 54: ASIA-PACIFIC: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 55: ASIA-PACIFIC: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: ROW: qPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 58: ROW: dPCR MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 59: ROW: qPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 60: ROW: dPCR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 61: ROW: qPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 62: ROW: dPCR MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 63: TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012-2015
  • TABLE 64: TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015
  • TABLE 65: TOP 5 MERGERS AND ACQUISITIONS, 2012-2015
  • TABLE 66: TOP 5 GEOGRAPHICAL EXPANSIONS, 2012-2015
  • TABLE 67: TOP OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2000-2013
  • FIGURE 3: HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS: 2000-2013
  • FIGURE 4: HEALTHCARE SPENDING MATRIX: KEY MARKETS (2013)
  • FIGURE 5: INCREASE IN AGING POPULATION, BY COUNTRY (2011-2030)
  • FIGURE 6: PERCENTAGE INCREASE IN AGING POPULATION, BY REGION (1980-2010 VS. 2010-2040)
  • FIGURE 7: GLOBAL BURDEN OF CANCER, BY REGION (2005-2030)
  • FIGURE 8: NUMBER OF NEW CANCER CASES, BY COUNTRY (2012 VS. 2020)
  • FIGURE 9: INCREASING INCIDENCE OF VARIOUS CANCERS, 2008-2020
  • FIGURE 10: ANNUAL BIRTH RATE IN DEVELOPED AND DEVELOPING NATIONS (2014)
  • FIGURE 11: GLOBAL PREVALENCE OF HIV INFECTIONS AMONG ADULTS (2013)
  • FIGURE 12: CRIMINAL CASES ACROSS KEY REGIONS: RAPE AND HOMICIDE (2003-2014)
  • FIGURE 13: NUMBER OF NEW PRODUCT LAUNCHES: qPCR AND dPCR VS. COMPETITIVE MODALITIES, 2012-2015
  • FIGURE 14: dPCR IS EXPECTED TO BE THE FASTEST-GROWING PCR TECHOLOGY TILL 2021
  • FIGURE 15: TOP-DOWN APPROACH
  • FIGURE 16: BOTTOM-UP APPROACH
  • FIGURE 17: DATA TRIANGULATION
  • FIGURE 18: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 19: GLOBAL qPCR AND dPCR MARKET, BY TECHNOLOGY, 2016 VS. 2021
  • FIGURE 20: GLOBAL qPCR AND dPCR PRODUCT AND SERVICES MARKET, 2016 VS. 2021
  • FIGURE 21: GLOBAL qPCR AND dPCR APPLICATIONS MARKET, 2016 VS. 2021
  • FIGURE 22: qPCR AND dPCR MARKET SHARE, BY REGION, 2016
  • FIGURE 23: MARKET GROWTH OPPORTUNITIES IN THE qPCR AND dPCR INDUSTRY
  • FIGURE 24: NORTH AMERICA EXPECTED TO DOMINATE qPCR AND dPCR MARKETS DURING THE STUDY PERIOD
  • FIGURE 25: REAGENTS AND CONSUMABLES TO DOMINATE THE qPCR AND dPCR PRODUCTS AND SERVICES MARKETS IN 2016
  • FIGURE 26: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF qPCR AND dPCR APPLICATIONS MARKETS IN 2016
  • FIGURE 27: NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF qPCR/dPCR APPLICATIONS MARKET IN 2016
  • FIGURE 28: HOSPITALS AND DIAGNOSTIC CENTERS TO DOMINATE THE qPCR END-USERS MARKET TILL 2021
  • FIGURE 29: KEY EVOLUTIONARY MILESTONES IN THE FIELD OF qPCR AND dPCR
  • FIGURE 30: RISING GERIATRIC POPULATION TO DRIVE THE MARKET DEMAND FOR dPCR AND qPCR PRODUCTS
  • FIGURE 31: HIV PREVALENCE, BY REGION, 2013
  • FIGURE 32: GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES (2015 VS. 2030)
  • FIGURE 33: TRADITIONAL PCR VS. qPCR: A COMPARATIVE STUDY
  • FIGURE 34: PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE-DEVELOPED VS. DEVELOPING COUNTRIES (2010-2013)
  • FIGURE 35: VALUE CHAIN ANALYSIS (2006-2013): MAJOR VALUE IS ADDED TO OVERALL PRODUCT PRICE DURING MANUFACTURING PHASE
  • FIGURE 36: BUNDLED SALES STRATEGY ADOPTED BY KEY PRODUCT MANUFACTURERS IS LIMITING THREAT FROM NEW ENTRANTS
  • FIGURE 37: GROWING NUMBER OF NEW ENTRANTS IS STRENGTHENING THE MARKET COMPETITION
  • FIGURE 38: dPCR TECHNOLOGY IS PROJECTED TO BE THE FASTEST-GROWING TECHNOLOGY SEGMENT TILL 2021
  • FIGURE 39: qPCR REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO DOMINATE THE qPCR PRODUCTS & SERVICES MARKET DURING 2016-2021
  • FIGURE 40: dPCR INSTRUMENTS EXPECTED TO DOMINATE THE DPCR PRODUCTS & SERVICES MARKET DURING 2016-2021
  • FIGURE 41: CLINICAL APPLICATIONS TO DOMINATE GLOBAL qPCR MARKET DURING 2016-2021
  • FIGURE 42: CLINICAL APPLICATIONS TO DOMINATE GLOBAL dPCR MARKET DURING 2016-2021
  • FIGURE 43: HOSPITALS AND DIAGNOSTIC CENTERS TO DOMINATE THE qPCR END USER MARKET DURING 2016-2021
  • FIGURE 44: RESEARCH LABS AND ACADEMIC INSTITUTES TO DOMINATE THE dPCR END-USER MARKET DURING 2016-2021
  • FIGURE 45: NORTH AMERICAN qPCR AND dPCR MARKET SNAPSHOT (2016-2021)
  • FIGURE 46: EUROPEAN qPCR AND dPCR MARKET SNAPSHOT (2016-2021)
  • FIGURE 47: ASIA-PACIFIC qPCR AND dPCR MARKET SNAPSHOT (2016-2021)
  • FIGURE 48: ROW qPCR AND dPCR MARKET SNAPSHOT (2016-2021)
  • FIGURE 49: LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS AS THEIR KEY GROWTH STRATEGY DURING 2012-2015
  • FIGURE 50: GLOBAL qPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
  • FIGURE 51: GLOBAL dPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
  • FIGURE 52: INCREASE IN NUMBER OF INNOVATIVE qPCR AND dPCR PRODUCTS IS STIMULATING MARKET GROWTH
  • FIGURE 53: GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS (2015)
  • FIGURE 54: PRODUCT DEVELOPMENT AND COMMERCIALIZATION, THE KEY GROWTH STRATEGY ADOPTED BY QPCR AND DPCR MARKET PLAYERS
  • FIGURE 55: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 56: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 57: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 58: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 59: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 60: TAKARA BIO, INC.: COMPANY SNAPSHOT
  • FIGURE 61: BIOMERIEUX S.A.: COMPANY SNAPSHOT
  • FIGURE 62: AFFYMETRIX, INC.: COMPANY SNAPSHOT
  • FIGURE 63: FLUIDIGM CORPORATION: COMPANY SNAPSHOT
Back to Top